EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Dynamic Interference Testing Results with the Dexcom G6 Continuous Glucose Monitoring Device

Nicole Thomé, Hendrick Jensch, Geethan Srikanthamoorthy, Lea Weingärtner, Mike Grady, Steven Setford, Elizabeth Holt, Andreas Pfützner

Diabetes Technology and Obesity Medicine · 2025

DOI: 10.1089/dtom.2024.0009 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetes Technology and Obesity Medicine, 2025. Verfasst von Nicole Thomé und 7 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Continuous glucose monitoring (CGM) is becoming a standard diagnostic procedure in people with diabetes. However, little is known about how glucose oxidase-based interstitial sensors react to potentially interfering substances. We report on in vitro dynamic interference testing with Dexcom G6 sensors.

Methods

Using pressure liquid chromatography (HPLC) pump-controlled substance gradients, we exposed sensors to varying concentrations of 69 substances in triplicate using YSI Stat 2300 Plus as glucose reference.

Results

Interference was assumed if the device showed more than ±10% bias over baseline, and it was seen for Dexcom G6 with the following substances: acetaminophen, dithiothreitol, ethyl alcohol, galactose, gentisic acid, hydroxyurea, l -cysteine, l -dopa, mannose, N -acetyl-cysteine, and uric acid. Additionally, sensors could not subsequently be calibrated for use after exposure to dithiothreitol, gentisic acid, l -cysteine, and mesalazine (sensor fouling). Interference testing identified several nutritional, pharmacological, and endogenous substances that biased the Dexcom G6 signal in vitro.

Conclusions

The in vitro test protocol cannot replace appropriate clinical testing, but if confirmed clinically, such interferences should be considered when making treatment decisions using Dexcom G6 readings. More research on the interference behavior of CGM sensors is strongly recommended before using them broadly in automated insulin delivery systems with insulin pumps.

Zitieren

APA

Thomé, N., Jensch, H., Srikanthamoorthy, G., Weingärtner, L., Grady, M., Setford, S., Holt, E., & Pfützner, A. (2025). Dynamic Interference Testing Results with the Dexcom G6 Continuous Glucose Monitoring Device. Diabetes Technology and Obesity Medicine. https://doi.org/10.1089/dtom.2024.0009

Vancouver

Thomé N, Jensch H, Srikanthamoorthy G, Weingärtner L, Grady M, Setford S, et al. Dynamic Interference Testing Results with the Dexcom G6 Continuous Glucose Monitoring Device. Diabetes Technology and Obesity Medicine. 2025. doi:10.1089/dtom.2024.0009

BibTeX
@article{Thom2025,
  author = {Thomé, Nicole and Jensch, Hendrick and Srikanthamoorthy, Geethan and Weingärtner, Lea and Grady, Mike and Setford, Steven and Holt, Elizabeth and Pfützner, Andreas},
  title = {Dynamic Interference Testing Results with the Dexcom G6 Continuous Glucose Monitoring Device},
  journal = {Diabetes Technology and Obesity Medicine},
  year = {2025},
  doi = {10.1089/dtom.2024.0009}
}
Kostenlos starten →